Cell Cryopreservation Market - Strategic Insights and Forecasts (2025-2030)

The global cell cryopreservation market is projected to grow at a CAGR of 22.4% during the forecast period, driven by expanding applications in regenerative medicine, IVF, and cell-based therapies.

Growth is fueled by rising demand for stem cell and regenerative therapies, advancements in cryoprotectant technologies, and strategic collaborations between biotech firms and CDMOs, such as partnerships between Cryoport Inc. and Cell Matters S.A. for cryopreservation services.

The market faces challenges related to the high cost of cryopreservation equipment, cryoprotectants, and storage facilities. Additionally, maintaining precise freezing and thawing conditions adds to operational expenses, particularly for large-scale applications.

Europe is expected to hold a significant share, driven by projects such as CRYOSOCIETIES, which explore the societal and scientific impact of cryopreservation across regenerative medicine, reproductive health, and species conservation. North America also remains a major contributor due to strong biotech infrastructure.

The market is expected to witness transformative growth as AI-integrated cryopreservation systems, automated storage technologies, and DMSO-free freezing media enhance efficiency and safety. By 2029, the industry will play a pivotal role in personalized medicine, fertility preservation, and organ transplantation.